Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 810 of 1,261

  1. US 8748591

    Chimeric sindbis-western equine encephalitis virus and uses thereof

    The Board of Regents of the University of Texas System · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  2. US 8748176

    Generation of choroid plexus epithelial cells from human embryonic stem cells

    The Regents of the University of California · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  3. US 8748385

    Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  4. US 8748657

    Process to prepare treprostinil

    United Therapeutics Corporation · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  5. US 8748648

    Oligomer-calcium channel blocker conjugates

    Nektar Therapeutics · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  6. US 8748597

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  7. US 8748601

    Selective serine/threonine kinase inhibitors

    The Regents of the University of California · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  8. US 8748607

    Imidazopyrizine syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  9. US 8748625

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid

    PTC THERAPEUTICS, INC. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  10. US 8748612

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  11. US 8748633

    Selective androgen receptor modulators (SARMs) and uses thereof

    Ligand Pharmaceuticals Incorporated · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  12. US 8748621

    1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones

    Addex Pharma, S.A. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  13. US 8747845

    Methods of treatment by administering antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  14. US 8748390

    Immunogenic epitopes of NGEP antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  15. US 8748114

    ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  16. US 8747872

    Nanoemulsion therapeutic compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  17. US 8747823

    Compositions and methods for treating a keratin based substrate

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  18. US 8747843

    Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor

    The Board of Regents of the University of Texas System · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  19. US 8747859

    Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  20. US 8747863

    Vaccine for shigella

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  21. US 8747919

    Pharmaceutical composition and method of preparing same

    SAISEI MIRAI CLINIC · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  22. US 8748396

    Lyophilization of synthetic liposomal pulmonary surfactant

    Discovery Laboratories, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  23. US 8747883

    Medical item for long term drug release

    Princeton Trade & Technology, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  24. US 8748397

    Lyophilization of synthetic liposomal pulmonary surfactant

    Discovery Laboratories, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.